Literature DB >> 22870149

MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa.

Guoren Deng1, Sanjay Kakar, Young S Kim.   

Abstract

MicroRNAs (miRs) are a class of small RNAs that regulate gene expression at the post-transcriptional and/or translational level by interacting with their target mRNAs. miRs are down-regulated or up-regulated in various cancer types, triggering abnormal cell differentiation, proliferation and apoptosis. miR-124a and miR-34b/c have been reported to be expressed at lower levels in colorectal cancer (CRC) due to methylation of these genes. The present study aimed to determine the methylation status of miR-124a and miR-34b/c in CRCs and polyps of various histological types, adjacent normal mucosa and ulcerative colitis. The colon cancer cell line study showed an association of the lower expression of miR-124a and miR-34b/c with the methylation of these genes and induction of the expression of these genes with the treatment by 5-aza-2'-deoxycytidine. Among nine different cancer types examined, CRC showed the highest frequency of methylation of miR-124a (cell lines 88% and tissues 99%) and miR-34b/c (cell lines 89% and tissues 93%). Mucinous and non-mucinous CRCs and all the histological types of colorectal polyps showed a high frequency of methylation of miR-124a and miR-34b/c. Notably, methylation of miR-124a (59%) and miR-34b/c (26%) was observed in the adjacent normal mucosa of CRC patients, but not in colonic mucosa from patients without cancer or with ulcerative colitis. The methylation of miR-124a in the adjacent normal mucosa was associated with the microsatellite instability of CRC, while the methylation of miR-34b/c was associated with an older age at diagnosis of CRC. The results showed that the methylation of miR-124a and miR-34b/c occured early in colorectal carcinogenesis and certain CRCs may arise from a field defect defined by the epigenetic inactivation of miRs.

Entities:  

Year:  2010        PMID: 22870149      PMCID: PMC3412539          DOI: 10.3892/ol.2010.222

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

Review 1.  microRNAs join the p53 network--another piece in the tumour-suppression puzzle.

Authors:  Lin He; Xingyue He; Scott W Lowe; Gregory J Hannon
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

2.  Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia.

Authors:  Young S Kim; Guoren Deng
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

3.  MGMT promoter methylation and field defect in sporadic colorectal cancer.

Authors:  Lanlan Shen; Yutaka Kondo; Gary L Rosner; Lianchun Xiao; Natalie Supunpong Hernandez; Jill Vilaythong; P Scott Houlihan; Robert S Krouse; Anil R Prasad; Janine G Einspahr; Julie Buckmeier; David S Alberts; Stanley R Hamilton; Jean-Pierre J Issa
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

Review 4.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer.

Authors:  Guoren Deng; Anh Nguyen; Hirofumi Tanaka; Koji Matsuzaki; Ian Bell; Kshama R Mehta; Jonathan P Terdiman; Frederic M Waldman; Sanjay Kakar; James Gum; Suzanne Crawley; Marvin H Sleisenger; Young S Kim
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

6.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

Authors:  Amaia Lujambio; Santiago Ropero; Esteban Ballestar; Mario F Fraga; Celia Cerrato; Fernando Setién; Sara Casado; Ana Suarez-Gauthier; Montserrat Sanchez-Cespedes; Anna Git; Anna Gitt; Inmaculada Spiteri; Partha P Das; Carlos Caldas; Eric Miska; Manel Esteller
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

Review 7.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 8.  CpG island methylator phenotype in cancer.

Authors:  Jean-Pierre Issa
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

9.  Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.

Authors:  Yong Ho Kim; Sanjay Kakar; Lisa Cun; Guoren Deng; Young S Kim
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

10.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more
  18 in total

1.  Epigenetic field defects in progression to cancer.

Authors:  Carol Bernstein; Valentine Nfonsam; Anil Ramarao Prasad; Harris Bernstein
Journal:  World J Gastrointest Oncol       Date:  2013-03-15

2.  A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Koji Tanaka; Toshimitsu Araki; Keiichi Uchida; Asahi Hishida; Motoi Uchino; Hiroki Ikeuchi; Seiichi Hirota; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2017-08-25       Impact factor: 22.682

Review 3.  Field cancerisation in colorectal cancer: a new frontier or pastures past?

Authors:  Abhilasha Patel; Gyanendra Tripathi; Kishore Gopalakrishnan; Nigel Williams; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

4.  Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.

Authors:  Feng Wang; Yanlei Ma; Huamin Wang; Huanlong Qin
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

Review 5.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

6.  Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.

Authors:  Hui-Deng Long; Yu-Shui Ma; Hui-Qiong Yang; Shao-Bo Xue; Ji-Bin Liu; Fei Yu; Zhong-Wei Lv; Ji-Yu Li; Ru-Ting Xie; Zheng-Yan Chang; Gai-Xia Lu; Wen-Ting Xie; Da Fu; Li-Juan Pang
Journal:  Mol Biol Rep       Date:  2018-10-19       Impact factor: 2.316

7.  Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.

Authors:  Riadh Ben Gacem; Olfa Ben Abdelkrim; Sonia Ziadi; Myriam Ben Dhiab; Mounir Trimeche
Journal:  Tumour Biol       Date:  2013-12-29

8.  Correlations of microRNA-124a and microRNA-30d with clinicopathological features of breast cancer patients with type 2 diabetes mellitus.

Authors:  Yu-Ling Han; Xian-E Cao; Ju-Xun Wang; Chun-Ling Dong; Hong-Tao Chen
Journal:  Springerplus       Date:  2016-12-22

9.  MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.

Authors:  Xianglai Xu; Shiqi Li; Yiwei Lin; Hong Chen; Zhenghui Hu; Yeqing Mao; Xin Xu; Jian Wu; Yi Zhu; Xiangyi Zheng; Jindan Luo; Liping Xie
Journal:  J Transl Med       Date:  2013-11-02       Impact factor: 5.531

10.  The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.

Authors:  Xiaowei Li; Liguang Wang; Jianyu Yu; Jun Xu; Jiajun Du
Journal:  Tumour Biol       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.